Anti human Gas6 monoclonal antibody

Patent metadata

Field	Value
Publication number	US-10561727-B2
Application number	US-201515520623-A
Country	US
Kind code	B2
Filing date	Oct 20, 2015
Priority date	Oct 21, 2014
Publication date	Feb 18, 2020
Grant date	Feb 18, 2020

Abstract

The present invention relates to an antibody specifically binding to human growth arrest specific 6 (hGas6). Specifically, the present invention relates to a monoclonal antibody or an antibody fragment thereof which binds to at least one of amino acid residues at positions 314, 315, and 316 of human Gas6, a nucleic acid comprising a nucleotide sequence encoding the antibody or the antibody fragment, a transformed cell comprising a vector comprising the nucleic acid, a method for producing the antibody or the antibody fragment, a reagent for detection or assay of Gas6, comprising the antibody or the antibody fragment, a therapeutic agent or a diagnostic agent for a Gas6-related disease, comprising the antibody or the antibody fragment as an active ingredient, and use of the antibody or the antibody fragment for the production of a therapeutic agent or a diagnostic agent for a Gas6-related disease.

First claim

The invention claimed is:

1. A monoclonal antibody or an antibody fragment thereof which binds to at least one of amino acid residues at positions 314, 315, and 316 in the amino acid sequence of human Gas6 shown in SEQ ID NO: 4, wherein the monoclonal antibody is
an antibody in which the amino acid sequences of heavy chain (hereinafter, abbreviated to H chain) variable region (hereinafter, abbreviated to VH) complementarity determining region (hereinafter, abbreviated to CDR) 1 to CDR3 are the amino acid sequences shown in SEQ ID NOs: 79, 80, and 81, respectively, and the amino acid sequences of light chain (hereinafter, abbreviated to L chain) variable region (hereinafter, abbreviated to VL) CDR1 to CDR3 are the amino acid sequences shown in SEQ ID NOs: 82, 83, and 84, respectively.

2. The monoclonal antibody or the antibody fragment thereof according to claim 1 , wherein the monoclonal antibody is any one antibody selected from the following antibodies (a) and (b):
(a) an antibody in which the amino acid sequence of VH is the amino acid sequence shown in SEQ ID NO: 69, and the amino acid sequence of VL is the amino acid sequence shown in SEQ ID NO: 72;
(b) an antibody in which the amino acid sequence of VH is the amino acid sequence shown in SEQ ID NO: 135, and the amino acid sequence of VL is the amino acid sequence shown in SEQ ID NO: 123.

3. The monoclonal antibody or the antibody fragment thereof according to claim 1 , wherein the monoclonal antibody is a recombinant antibody.

4. The monoclonal antibody or the antibody fragment thereof according to claim 3 , wherein the recombinant antibody is a recombinant antibody selected from a human chimeric antibody, and a humanized antibody.

5. The monoclonal antibody or the antibody fragment according to claim 1 , wherein the monoclonal antibody or the antibody fragment is selected from Fab, Fab′, F(ab′) 2 , single chain Fv (scFv), diabody, and disulfide-stabilized Fv (dsFv).

6. A reagent for detection or assay of Gash, comprising the antibody or the antibody fragment thereof according to claim 1 and an agent to label the antibody.

7. A therapeutic agent comprising the antibody or the antibody fragment thereof according to claim 1 as an active ingredient and one or more pharmaceutically acceptable carriers.

8. A diagnostic agent comprising the antibody or the antibody fragment thereof according to claim 1 as an active ingredient and a reagent for detecting antigen-antibody reaction.

Assignees

• Kyowa Kirin Co Ltd

Inventors

• Ube Yuko
• Yamada Tsuyoshi
• Yamazaki Yuji
• Kimura Kaname
• Hariguchi Akiko
• Ogawa Shinya

Classifications

• A61P3/10

  for hyperglycaemia, e.g. antidiabetics · CPC title

• A61P35/00

  Antineoplastic agents · CPC title

• A61P13/12

  of the kidneys · CPC title

• C07K16/28

  against receptors, cell surface antigens or cell surface determinants · CPC title

• C07K2317/14

  Specific host cells or culture conditions, e.g. components, pH or temperature · CPC title